Tian Tiffany, Aaron Rachel E, Seley Jane Jeffrie, Longo Rebecca, Nayberg Irina, Umpierrez Guillermo E, Levy Carol J, Klonoff David C
Diabetes Technology Society, Burlingame, CA, USA.
Division of Endocrinology, Diabetes & Metabolism, Weill Cornell Medicine, New York, NY, USA.
J Diabetes Sci Technol. 2024 Jan;18(1):207-214. doi: 10.1177/19322968231200847. Epub 2023 Oct 2.
Continuous glucose monitors (CGMs) have increasingly been used in ambulatory and inpatient or hospital settings to improve glycemic outcomes for people with diabetes. Given their capacity to aid individuals in avoiding hypo- and hyperglycemia, they may also be useful when transitioning from hospital to home by reducing rates of hospital readmissions and emergency department visits. Several types of barriers presently exist that make the deployment of CGMs at the time of hospital discharge problematic, including (1) regulatory, (2) behavioral, (3) logistical, (4) technical, (5) staffing, and (6) systemic issues. In this commentary, we review the literature, discuss these barriers, and propose possible solutions to facilitate the use of CGMs in people with diabetes at the time of hospital discharge.
连续血糖监测仪(CGMs)越来越多地用于门诊、住院或医院环境中,以改善糖尿病患者的血糖结果。鉴于其有助于个人避免低血糖和高血糖的能力,在从医院过渡到家庭时,通过降低再次入院率和急诊就诊率,它们可能也很有用。目前存在几种类型的障碍,使得在出院时部署连续血糖监测仪存在问题,包括(1)监管、(2)行为、(3)后勤、(4)技术、(5)人员配备和(6)系统问题。在这篇评论中,我们回顾了文献,讨论了这些障碍,并提出了可能的解决方案,以促进糖尿病患者在出院时使用连续血糖监测仪。